Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Public ClinicalTrials.gov record NCT03077412. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Study identification
- NCT ID
- NCT03077412
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Interventions
- Filgotinib Drug
- Placebo to match filgotinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 5, 2017
- Primary completion
- Jan 19, 2021
- Completion
- Feb 16, 2021
- Last update posted
- Apr 7, 2022
2017 – 2021
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Miami Crohn's and Colitis Center | Miami | Florida | 33136 | — |
| Center for Interventional Endoscopy - Florida Hospital | Orlando | Florida | 32804 | — |
| University of South Florida South Tampa Campus | Tampa | Florida | 33606 | — |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| University of Louisville Clinical Trials Unit | Louisville | Kentucky | 40202 | — |
| John Hopkins Gastroenterology and Hepatology Services at the Green Spring Station Clinic | Baltimore | Maryland | 21224 | — |
| Gastro Center of Maryland | Columbia | Maryland | 21045 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| Vanderbilt University Medical Center - IBD Clinic | Nashville | Tennessee | 37212-2702 | — |
| Texas Clinical Research Institute | Arlington | Texas | 76012 | — |
| DHAT Research Institute | Garland | Texas | 75044 | — |
| Texas Digestive Disease Consultants | Southlake | Texas | 76092 | — |
| McGuire DVAMC | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03077412, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03077412 live on ClinicalTrials.gov.